Remember, the GLP study gets the glory — but the DRF study is the one who put the work in. Go break some eggs.
👀 The Read
The GLP study is not really your pivotal study.
Your DRF is.
Everyone treats the GLP tox study as the main event. It's the expensive one, the pivotal one, the one that goes in the IND. So it gets the attention, the budget, and the anxiety.
But by the time you're running the GLP study, you've already made every decision that matters. The GLP study doesn't find your dose, your species, or your target organs — it confirms them. It's a clean recording of choices you locked in earlier. And you locked them in during the study most teams overlook: the dose-range finder.
The DRF is where the actual science happens. It's where you find out what your compound does to an animal, at what exposures, in which organs, on what timeline. It's where you learn whether your high dose is tolerable or lethal, whether toxicity is cellular, whether the two species even agree. Every number that ends up in your GLP protocol — the dose levels, the endpoints you emphasize, the exposures you anchor to — comes out of the DRF. Get the DRF right and the GLP study is a formality. Get it wrong and you run a perhaps fully compliant GLP around the wrong doses (and you've spent the big money confirming a mistake).
That’s the trap.
A GLP study design isn’t created out of thin air, it was set by the DRF. If your dose-range finder was overlooked, underpowered, or shortened to save time, the GLP study inherits every one of those errors — at ten times the cost and with no room to adjust.
In general, the money and the care are usually pointed at the wrong study. The DRF is cheaper, non-GLP, and easy to treat as a throwaway — which is exactly why it's where programs can go wrong.
The DRF study is where you find the answer. The GLP study is where you prove it.
Underinvest (and not just monetarily) in the DRF and the GLP study won’t save you. In fact, it could bury you and your program. A perfect recording of the wrong doses is still the wrong doses — and by then it's a different problem entirely.
The Misconception: The GLP study is the important one, the DRF is a warm-up.
The Correction: The GLP study confirms your doses, species, and target organs — it doesn't find them. The DRF is where the real science happens: exposure understanding, target organ insights, species alignment.
Rule of Thumb: your DRF should be 50% of the intended duration of your GLP.
✍ Learn how to design a DRF study that will enable a bulletproof GLP study
Modules 2 and 3 in my online course go over how to strategically use nonGLP studies to your advantage, and how to design them to support an IND-defensible nonclinical program. See the full syllabus below plus a Free Preview:
The most comprehensive nonclinical development course in the industry → https://www.nonclinical.academy/